Regeneron Pharmaceuticals, Inc. (REGN)
USD 581.68
(-4.74%)
USD 581.68
(-4.74%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 7.1 Billion USD | 8.5% |
| 2022 | 6.55 Billion USD | -1.73% |
| 2021 | 6.66 Billion USD | 8.6% |
| 2020 | 6.13 Billion USD | 65.2% |
| 2019 | 3.71 Billion USD | 24.8% |
| 2018 | 2.97 Billion USD | 13.62% |
| 2017 | 2.62 Billion USD | 3.8% |
| 2016 | 2.52 Billion USD | 29.16% |
| 2015 | 1.95 Billion USD | 46.99% |
| 2014 | 1.32 Billion USD | 33.09% |
| 2013 | 998.93 Million USD | 19.62% |
| 2012 | 835.1 Million USD | -0.33% |
| 2011 | 837.85 Million USD | 49.19% |
| 2010 | 561.61 Million USD | 63.05% |
| 2009 | 344.44 Million USD | 37.13% |
| 2008 | 251.18 Million USD | -47.23% |
| 2007 | 475.99 Million USD | 29.18% |
| 2006 | 368.46 Million USD | 19.05% |
| 2005 | 309.49 Million USD | 6.52% |
| 2004 | 290.56 Million USD | -15.02% |
| 2003 | 341.91 Million USD | 39.22% |
| 2002 | 245.59 Million USD | 7.23% |
| 2001 | 229.04 Million USD | 776.08% |
| 2000 | 26.14 Million USD | -4.93% |
| 1999 | 27.5 Million USD | 7.0% |
| 1998 | 25.7 Million USD | -12.88% |
| 1997 | 29.5 Million USD | -3.91% |
| 1996 | 30.7 Million USD | 18.53% |
| 1995 | 25.9 Million USD | -4.43% |
| 1994 | 27.1 Million USD | 41.15% |
| 1993 | 19.2 Million USD | 79.44% |
| 1992 | 10.7 Million USD | 37.18% |
| 1991 | 7.8 Million USD | -40.91% |
| 1990 | 13.2 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 7.88 Billion USD | 6.81% |
| 2024 Q1 | 7.37 Billion USD | 3.82% |
| 2024 Q3 | 8.11 Billion USD | 2.98% |
| 2023 Q1 | 6.56 Billion USD | 0.22% |
| 2023 Q4 | 7.1 Billion USD | -2.09% |
| 2023 FY | 7.1 Billion USD | 8.5% |
| 2023 Q2 | 6.63 Billion USD | 1.14% |
| 2023 Q3 | 7.25 Billion USD | 9.33% |
| 2022 Q2 | 6.51 Billion USD | 1.31% |
| 2022 Q3 | 6.23 Billion USD | -4.28% |
| 2022 FY | 6.55 Billion USD | -1.73% |
| 2022 Q1 | 6.43 Billion USD | -3.48% |
| 2022 Q4 | 6.55 Billion USD | 4.99% |
| 2021 FY | 6.66 Billion USD | 8.6% |
| 2021 Q2 | 6.35 Billion USD | 9.72% |
| 2021 Q1 | 5.79 Billion USD | -5.58% |
| 2021 Q3 | 6.41 Billion USD | 0.86% |
| 2021 Q4 | 6.66 Billion USD | 3.94% |
| 2020 Q2 | 5.37 Billion USD | 48.19% |
| 2020 FY | 6.13 Billion USD | 65.2% |
| 2020 Q1 | 3.62 Billion USD | -2.45% |
| 2020 Q4 | 6.13 Billion USD | 3.01% |
| 2020 Q3 | 5.95 Billion USD | 10.93% |
| 2019 FY | 3.71 Billion USD | 24.8% |
| 2019 Q1 | 3.41 Billion USD | 14.54% |
| 2019 Q2 | 3.41 Billion USD | 0.22% |
| 2019 Q4 | 3.71 Billion USD | 8.17% |
| 2019 Q3 | 3.43 Billion USD | 0.5% |
| 2018 Q4 | 2.97 Billion USD | 1.36% |
| 2018 FY | 2.97 Billion USD | 13.62% |
| 2018 Q3 | 2.93 Billion USD | 6.21% |
| 2018 Q2 | 2.76 Billion USD | -1.41% |
| 2018 Q1 | 2.8 Billion USD | 7.05% |
| 2017 FY | 2.62 Billion USD | 3.8% |
| 2017 Q4 | 2.62 Billion USD | -1.11% |
| 2017 Q1 | 2.95 Billion USD | 16.92% |
| 2017 Q2 | 2.58 Billion USD | -12.39% |
| 2017 Q3 | 2.64 Billion USD | 2.47% |
| 2016 Q3 | 2.33 Billion USD | 9.79% |
| 2016 Q4 | 2.52 Billion USD | 8.02% |
| 2016 Q2 | 2.12 Billion USD | -0.51% |
| 2016 Q1 | 2.13 Billion USD | 9.47% |
| 2016 FY | 2.52 Billion USD | 29.16% |
| 2015 Q4 | 1.95 Billion USD | 3.62% |
| 2015 Q3 | 1.88 Billion USD | 58.69% |
| 2015 Q1 | 1.22 Billion USD | -7.7% |
| 2015 FY | 1.95 Billion USD | 46.99% |
| 2015 Q2 | 1.18 Billion USD | -3.15% |
| 2014 FY | 1.32 Billion USD | 33.09% |
| 2014 Q1 | 1.04 Billion USD | 5.03% |
| 2014 Q2 | 1.08 Billion USD | 3.63% |
| 2014 Q3 | 1.18 Billion USD | 9.23% |
| 2014 Q4 | 1.32 Billion USD | 11.95% |
| 2013 Q4 | 998.93 Million USD | 5.12% |
| 2013 FY | 998.93 Million USD | 19.62% |
| 2013 Q1 | 869.65 Million USD | 4.14% |
| 2013 Q2 | 884.92 Million USD | 1.76% |
| 2013 Q3 | 950.24 Million USD | 7.38% |
| 2012 Q1 | 846.13 Million USD | 0.99% |
| 2012 Q2 | 862.84 Million USD | 1.97% |
| 2012 Q3 | 854.59 Million USD | -0.96% |
| 2012 FY | 835.1 Million USD | -0.33% |
| 2012 Q4 | 835.1 Million USD | -2.28% |
| 2011 Q2 | 568.83 Million USD | 2.27% |
| 2011 FY | 837.85 Million USD | 49.19% |
| 2011 Q4 | 837.85 Million USD | 51.02% |
| 2011 Q3 | 554.77 Million USD | -2.47% |
| 2011 Q1 | 556.2 Million USD | -0.96% |
| 2010 Q1 | 400.88 Million USD | 16.39% |
| 2010 FY | 561.61 Million USD | 63.05% |
| 2010 Q4 | 561.61 Million USD | -5.51% |
| 2010 Q3 | 594.36 Million USD | 41.71% |
| 2010 Q2 | 419.42 Million USD | 4.62% |
| 2009 Q4 | 344.44 Million USD | 7.72% |
| 2009 FY | 344.44 Million USD | 37.13% |
| 2009 Q1 | 271.1 Million USD | 7.93% |
| 2009 Q2 | 331.83 Million USD | 22.4% |
| 2009 Q3 | 319.74 Million USD | -3.64% |
| 2008 Q1 | 470.27 Million USD | -1.2% |
| 2008 FY | 251.18 Million USD | -47.23% |
| 2008 Q2 | 400.22 Million USD | -14.89% |
| 2008 Q3 | 388.95 Million USD | -2.82% |
| 2008 Q4 | 251.18 Million USD | -35.42% |
| 2007 Q1 | 404.74 Million USD | 9.85% |
| 2007 FY | 475.99 Million USD | 29.18% |
| 2007 Q3 | 421.69 Million USD | 0.76% |
| 2007 Q2 | 418.52 Million USD | 3.4% |
| 2007 Q4 | 475.99 Million USD | 12.87% |
| 2006 Q1 | 299.76 Million USD | -3.14% |
| 2006 Q3 | 292.71 Million USD | -0.63% |
| 2006 FY | 368.46 Million USD | 19.05% |
| 2006 Q4 | 368.46 Million USD | 25.88% |
| 2006 Q2 | 294.56 Million USD | -1.74% |
| 2005 Q4 | 309.49 Million USD | 9.4% |
| 2005 Q3 | 282.89 Million USD | 0.36% |
| 2005 FY | 309.49 Million USD | 6.52% |
| 2005 Q2 | 281.88 Million USD | -0.92% |
| 2005 Q1 | 284.5 Million USD | -2.08% |
| 2004 Q3 | 293.81 Million USD | -1.42% |
| 2004 FY | 290.56 Million USD | -15.02% |
| 2004 Q4 | 290.56 Million USD | -1.11% |
| 2004 Q1 | 302.07 Million USD | -11.65% |
| 2004 Q2 | 298.04 Million USD | -1.33% |
| 2003 Q3 | 344.29 Million USD | 33.6% |
| 2003 Q2 | 257.7 Million USD | -2.69% |
| 2003 Q4 | 341.91 Million USD | -0.69% |
| 2003 FY | 341.91 Million USD | 39.22% |
| 2003 Q1 | 264.82 Million USD | 7.83% |
| 2002 Q1 | 229.38 Million USD | 0.15% |
| 2002 Q3 | 237.8 Million USD | 4.62% |
| 2002 Q2 | 227.29 Million USD | -0.91% |
| 2002 FY | 245.59 Million USD | 7.23% |
| 2002 Q4 | 245.59 Million USD | 3.28% |
| 2001 Q1 | 24.77 Million USD | -5.24% |
| 2001 Q4 | 229.04 Million USD | 864.71% |
| 2001 Q3 | 23.74 Million USD | 3.22% |
| 2001 Q2 | 23 Million USD | -7.16% |
| 2001 FY | 229.04 Million USD | 776.08% |
| 2000 FY | 26.14 Million USD | -4.93% |
| 2000 Q4 | 26.14 Million USD | 3.14% |
| 2000 Q3 | 25.34 Million USD | -3.06% |
| 2000 Q2 | 26.14 Million USD | -1.11% |
| 2000 Q1 | 26.43 Million USD | -3.86% |
| 1999 Q2 | 24.4 Million USD | -5.79% |
| 1999 FY | 27.5 Million USD | 7.0% |
| 1999 Q4 | 27.5 Million USD | 15.06% |
| 1999 Q3 | 23.9 Million USD | -2.05% |
| 1999 Q1 | 25.9 Million USD | 0.78% |
| 1998 Q4 | 25.7 Million USD | 0.78% |
| 1998 Q1 | 26 Million USD | -11.86% |
| 1998 Q2 | 27.3 Million USD | 5.0% |
| 1998 Q3 | 25.5 Million USD | -6.59% |
| 1998 FY | 25.7 Million USD | -12.88% |
| 1997 Q2 | 30.1 Million USD | 7.12% |
| 1997 Q3 | 26.5 Million USD | -11.96% |
| 1997 Q4 | 29.5 Million USD | 11.32% |
| 1997 Q1 | 28.1 Million USD | -8.47% |
| 1997 FY | 29.5 Million USD | -3.91% |
| 1996 Q2 | 26.5 Million USD | 9.96% |
| 1996 Q1 | 24.1 Million USD | -6.95% |
| 1996 FY | 30.7 Million USD | 18.53% |
| 1996 Q3 | 26.4 Million USD | -0.38% |
| 1996 Q4 | 30.7 Million USD | 16.29% |
| 1995 FY | 25.9 Million USD | -4.43% |
| 1995 Q1 | 22.3 Million USD | -17.71% |
| 1995 Q3 | 21.2 Million USD | -11.67% |
| 1995 Q2 | 24 Million USD | 7.62% |
| 1995 Q4 | 25.9 Million USD | 22.17% |
| 1994 FY | 27.1 Million USD | 41.15% |
| 1994 Q4 | 27.1 Million USD | 10.16% |
| 1994 Q2 | 29.1 Million USD | 50.78% |
| 1994 Q1 | 19.3 Million USD | 0.52% |
| 1994 Q3 | 24.6 Million USD | -15.46% |
| 1993 Q2 | 14 Million USD | 9.38% |
| 1993 Q4 | 19.2 Million USD | 21.52% |
| 1993 FY | 19.2 Million USD | 79.44% |
| 1993 Q3 | 15.8 Million USD | 12.86% |
| 1993 Q1 | 12.8 Million USD | 19.63% |
| 1992 Q2 | 9.4 Million USD | 2.17% |
| 1992 FY | 10.7 Million USD | 37.18% |
| 1992 Q4 | 10.7 Million USD | -1.83% |
| 1992 Q1 | 9.2 Million USD | 17.95% |
| 1992 Q3 | 10.9 Million USD | 15.96% |
| 1991 Q3 | 5.6 Million USD | -5.08% |
| 1991 Q2 | 5.9 Million USD | 0.0% |
| 1991 FY | 7.8 Million USD | -40.91% |
| 1991 Q4 | 7.8 Million USD | 39.29% |
| 1990 Q4 | 13.2 Million USD | 0.0% |
| 1990 FY | 13.2 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -2016.619% |
| Alkermes plc | 933.53 Million USD | -661.309% |
| Agenus Inc. | 462.29 Million USD | -1437.352% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | -75.461% |
| Aptorum Group Limited | 5.25 Million USD | -135099.814% |
| Ardelyx, Inc. | 130.76 Million USD | -5335.1% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -1385.629% |
| Bicycle Therapeutics plc | 224.41 Million USD | -3066.988% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -5358.183% |
| ChromaDex Corporation | 26.5 Million USD | -26711.151% |
| Chimerix, Inc. | 19.74 Million USD | -35894.429% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -20103.76% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -9693.846% |
| CRISPR Therapeutics AG | 346.76 Million USD | -1949.526% |
| Precision BioSciences, Inc. | 140.92 Million USD | -4943.358% |
| Dyadic International, Inc. | 2.34 Million USD | -303537.749% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -43601.039% |
| Fortress Biotech, Inc. | 165.93 Million USD | -4182.959% |
| Lantern Pharma Inc. | 2.73 Million USD | -259313.319% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -9842.781% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -201307.024% |
| Incyte Corporation | 1.59 Billion USD | -346.35% |
| IO Biotech, Inc. | 17.55 Million USD | -40382.456% |
| Jaguar Health, Inc. | 45.86 Million USD | -15395.356% |
| Novavax, Inc. | 2.57 Billion USD | -176.297% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -19610.189% |
| Opthea Limited | 264.6 Million USD | -2585.966% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -5337.429% |
| ContextLogic Inc. | 206 Million USD | -3350.049% |
| MiMedx Group, Inc. | 96.33 Million USD | -7277.868% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -14699.675% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -201297.778% |
| NextCure, Inc. | 14.99 Million USD | -47290.145% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -175731.272% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -106341.516% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -15105.931% |
| Vaxcyte, Inc. | 167.44 Million USD | -4144.337% |
| PDS Biotechnology Corporation | 33.25 Million USD | -21268.867% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -2921.546% |
| Pharming Group N.V. | 244.07 Million USD | -2811.875% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -59513.32% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -5461.503% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -107464.703% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -107464.703% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -8521.669% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -106886.301% |
| Acelyrin, Inc. | 86.35 Million USD | -8130.287% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -546919.375% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -49326.942% |
| Summit Therapeutics Inc. | 125.25 Million USD | -5574.014% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -74877.318% |
| Senti Biosciences, Inc. | 52.57 Million USD | -13419.05% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -10233.542% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -4590.784% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -363248.671% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -532042.226% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -3033.2% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -75773.812% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -3024.755% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | -1337.203% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -65019.113% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -25733.667% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -58613.562% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -1360.56% |
| Immix Biopharma, Inc. | 3.72 Million USD | -190859.548% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -18695.885% |
| MEI Pharma, Inc. | 8.35 Million USD | -84964.034% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -24394.572% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -1944.738% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -4772.248% |
| Fortress Biotech, Inc. | 165.93 Million USD | -4182.959% |
| Precigen, Inc. | 41.64 Million USD | -16966.324% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -14134.128% |
| AlloVir, Inc. | 45.01 Million USD | -15688.293% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -5352.865% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -5057.547% |
| ImmuCell Corporation | 18.81 Million USD | -37673.535% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -25079.267% |
| Onconetix, Inc. | 23.18 Million USD | -30559.309% |
| PureTech Health plc | 125.58 Million USD | -5559.285% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -79308.939% |
| Elevation Oncology, Inc. | 34.28 Million USD | -20631.288% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -290578.937% |
| Seer, Inc. | 39.36 Million USD | -17954.363% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -11393.838% |
| Innoviva, Inc. | 568.55 Million USD | -1150.035% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -26002.174% |
| ESSA Pharma Inc. | 3.49 Million USD | -203246.37% |
| GlycoMimetics, Inc. | 6.9 Million USD | -102870.498% |
| GT Biopharma, Inc. | 6.63 Million USD | -107047.595% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -2588.112% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -2510.15% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -8358.215% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -72614.344% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -26058.858% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -220222.385% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -9534.525% |
| Aptose Biosciences Inc. | 15.8 Million USD | -44856.888% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -64277.737% |
| Soligenix, Inc. | 7.27 Million USD | -97593.385% |
| Century Therapeutics, Inc. | 175.94 Million USD | -3939.479% |
| Kura Oncology, Inc. | 51.66 Million USD | -13656.92% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -5759.979% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -171859.835% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -107357.753% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -2713.601% |
| Autolus Therapeutics plc | 263.9 Million USD | -2593.032% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -67702.9% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -7897.997% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -15054.054% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -1914.164% |
| GRI Bio, Inc. | 2.69 Million USD | -263418.725% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -877769.526% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -22759.027% |
| IGM Biosciences, Inc. | 220.17 Million USD | -3127.903% |
| INmune Bio, Inc. | 18.86 Million USD | -37579.461% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -2671.026% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -26576.489% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -261343.655% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -216562.307% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -12058.241% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -7290.988% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -2584.609% |
| Coherus BioSciences, Inc. | 823.02 Million USD | -763.53% |
| Verastem, Inc. | 71.18 Million USD | -9883.985% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -14352.375% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -18322.676% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -14424.442% |
| Histogen Inc. | 5.69 Million USD | -124651.624% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -161955.178% |
| Surrozen, Inc. | 8.14 Million USD | -87157.213% |
| Organovo Holdings, Inc. | 2.74 Million USD | -258528.093% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -2264331.686% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -12539.362% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -42942.03% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -13807.403% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -859413.228% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -5508.286% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -65623.779% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -4610.151% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -272479.962% |
| Apollomics, Inc. | 14.15 Million USD | -50116.209% |
| Amarin Corporation plc | 279.58 Million USD | -2441.999% |
| Mesoblast Limited | 188.79 Million USD | -3664.394% |
| Turnstone Biologics Corp. | 14.14 Million USD | -50133.955% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -3831.179% |
| Synaptogenix, Inc. | 5.52 Million USD | -128431.329% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -106805.836% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -4077.993% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -82954.104% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -404311.535% |
| Exelixis, Inc. | 678.44 Million USD | -947.557% |
| Better Therapeutics, Inc. | 23.84 Million USD | -29709.16% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -4232.382% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -1096.061% |
| NLS Pharmaceutics AG | 10.68 Million USD | -66444.609% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -437632.814% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -18157.508% |
| Gritstone bio, Inc. | 125.91 Million USD | -5544.184% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -48326.683% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -139566.358% |
| Avid Bioservices, Inc. | 275.66 Million USD | -2478.137% |
| Insmed Incorporated | 1.66 Billion USD | -327.685% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -92271.69% |
| MediWound Ltd. | 27.18 Million USD | -26041.538% |
| OmniAb, Inc. | 87.4 Million USD | -8031.693% |
| Alector, Inc. | 487.66 Million USD | -1357.361% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -1661.555% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -38473.134% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -18421.096% |
| Zai Lab Limited | 240.17 Million USD | -2859.109% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -1028.007% |
| Aura Biosciences, Inc. | 29.22 Million USD | -24216.899% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -7375.099% |
| Immunic, Inc. | 25.36 Million USD | -27916.004% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -10165.036% |
| Veracyte, Inc. | 93.71 Million USD | -7483.414% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -271508.26% |
| FibroGen, Inc. | 585.72 Million USD | -1113.379% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -40785.348% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -1088150.066% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -125567.983% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 7.174% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -86593.096% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -8358.618% |
| TG Therapeutics, Inc. | 169.08 Million USD | -4103.271% |
| Galecto, Inc. | 5.89 Million USD | -120441.045% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -85693.095% |
| Fortrea Holdings Inc. | 2.61 Billion USD | -171.429% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -24558.594% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -56211.703% |
| XBiotech Inc. | 8.39 Million USD | -84538.561% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -48326.683% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -13264.235% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -1857.307% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -26336.17% |
| Theravance Biopharma, Inc. | 169 Million USD | -4105.285% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | -484.658% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -1320.21% |
| Vaxxinity, Inc. | 30.94 Million USD | -22867.619% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | -630.816% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -117740.721% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -853.674% |
| NexImmune, Inc. | 5.08 Million USD | -139687.091% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -1913528.115% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -231036.629% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -137794.036% |
| Scopus BioPharma Inc. | 7.45 Million USD | -95240.572% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -26929.36% |
| Ainos, Inc. | 7.39 Million USD | -96016.928% |
| Pluri Inc. | 34.11 Million USD | -20734.604% |
| Prothena Corporation plc | 135.01 Million USD | -5163.856% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -2823.493% |
| Celularity Inc. | 102.92 Million USD | -6804.857% |
| Rallybio Corporation | 9.43 Million USD | -75218.991% |
| Cue Biopharma, Inc. | 24.44 Million USD | -28973.839% |
| MeiraGTx Holdings plc | 319.99 Million USD | -2121.031% |
| Omeros Corporation | 403.25 Million USD | -1662.446% |
| Humacyte, Inc. | 114.67 Million USD | -6097.494% |
| Immunocore Holdings plc | 228.15 Million USD | -3014.99% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -145686.667% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -9161.272% |
| Blueprint Medicines Corporation | 918.64 Million USD | -673.654% |
| CalciMedica, Inc. | 4.02 Million USD | -176342.403% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -40623.699% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -4510.719% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -8181.692% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -2458.416% |
| Pulmatrix, Inc. | 15.96 Million USD | -44422.333% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -44958.645% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -28783.606% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -2733.682% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -13894.208% |
| Cytokinetics, Incorporated | 1.21 Billion USD | -487.054% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -22261.325% |
| Nutriband Inc. | 1.07 Million USD | -658624.149% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -66740.026% |
| Vor Biopharma Inc. | 59.1 Million USD | -11924.736% |
| Roivant Sciences Ltd. | 773.95 Million USD | -818.286% |
| Evogene Ltd. | 17.99 Million USD | -39405.837% |
| ProKidney Corp. | 29.21 Million USD | -24226.054% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -9773.852% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -1008023.6% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | -276.253% |
| CorMedix Inc. | 11.91 Million USD | -59535.69% |
| BioLineRx Ltd. | 50.7 Million USD | -13917.396% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -4655.217% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -7935.979% |
| Atai Life Sciences N.V. | 49.16 Million USD | -14356.491% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -22714.041% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -39467.42% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -5602.285% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -125600.389% |
| MediciNova, Inc. | 3.89 Million USD | -182528.889% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -38781.23% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -472370.834% |
| GeoVax Labs, Inc. | 3.51 Million USD | -201813.076% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -1689.034% |
| Biomea Fusion, Inc. | 30.69 Million USD | -23057.706% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | -161.124% |
| Mereo BioPharma Group plc | 15.96 Million USD | -44425.122% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -22678.437% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -12010.797% |
| Absci Corporation | 58.3 Million USD | -12089.73% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -37211.529% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -22066.74% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -9531.522% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -8023.978% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -20945.603% |
| Allakos Inc. | 74.79 Million USD | -9402.36% |
| Imunon, Inc. | 8.53 Million USD | -83214.704% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -31485.707% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -6090.207% |
| BioAtla, Inc. | 48.98 Million USD | -14408.431% |
| NLS Pharmaceutics AG | 10.68 Million USD | -66444.609% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -255643.073% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -5341.717% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -49897.186% |
| XOMA Corporation | 145.58 Million USD | -4781.921% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -21011.243% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -10236.247% |
| aTyr Pharma, Inc. | 31.59 Million USD | -22392.958% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -11395.883% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -15705.849% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -14583.484% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -247534.146% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -87017.974% |
| Akari Therapeutics, Plc | 4.58 Million USD | -154941.449% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -39978.091% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | -330.874% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1759483.866% |
| UroGen Pharma Ltd. | 243.52 Million USD | -2818.451% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -2113.45% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -257258.346% |
| Orgenesis Inc. | 35.53 Million USD | -19900.281% |
| Entera Bio Ltd. | 1.37 Million USD | -515280.711% |
| GH Research PLC | 6.7 Million USD | -105960.29% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -104416.176% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -37651.514% |
| Xencor, Inc. | 283.55 Million USD | -2406.392% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -237939.974% |
| Replimune Group, Inc. | 113.21 Million USD | -6177.581% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -189063.256% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -6764.773% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -1759483.866% |
| Portage Biotech Inc. | 4.45 Million USD | -159610.112% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -472370.834% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -30733.406% |
| OncoCyte Corporation | 49.29 Million USD | -14316.609% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -171701.668% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -891090.293% |
| Purple Biotech Ltd. | 10 Million USD | -70935.482% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -122732.7% |
| scPharmaceuticals Inc. | 57.26 Million USD | -12311.764% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -57270.745% |
| HilleVax, Inc. | 78.9 Million USD | -8906.704% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -140634.653% |
| Tharimmune, Inc. | 1.81 Million USD | -391465.834% |
| Genprex, Inc. | 3.25 Million USD | -218297.226% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -26107.087% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -135635.294% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -3449948.544% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -1982089.275% |
| OKYO Pharma Limited | 7.42 Million USD | -95672.099% |
| Savara Inc. | 37.19 Million USD | -19009.217% |
| Curis, Inc. | 57.61 Million USD | -12236.145% |
| Daré Bioscience, Inc. | 26.32 Million USD | -26892.553% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -18030.453% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -492081.44% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -34037.567% |
| BeiGene, Ltd. | 2.23 Billion USD | -218.17% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -33282.653% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -2608.529% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -33307.446% |
| Erasca, Inc. | 78.61 Million USD | -8940.847% |
| bluebird bio, Inc. | 424.62 Million USD | -1573.74% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -1084536.14% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | -276.026% |
| DBV Technologies S.A. | 42.8 Million USD | -16505.374% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -1084536.14% |
| Moderna, Inc. | 4.57 Billion USD | -55.448% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -101502.573% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -429072.705% |
| Molecular Templates, Inc. | 31.17 Million USD | -22700.359% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -41535.032% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -1108.479% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -5608.285% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -25803.342% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -19395.008% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -12674.512% |
| MacroGenics, Inc. | 154.2 Million USD | -4508.805% |
| RenovoRx, Inc. | 4.46 Million USD | -159037.931% |
| Adicet Bio, Inc. | 37.12 Million USD | -19046.282% |
| Prime Medicine, Inc. | 60.78 Million USD | -11593.156% |
| Aditxt, Inc. | 28.53 Million USD | -24809.611% |
| Adagene Inc. | 45.16 Million USD | -15634.345% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -3932971.759% |
| Quantum-Si incorporated | 26.63 Million USD | -26587.319% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -918.843% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -233498.844% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -6082.184% |
| SciSparc Ltd. | 1.59 Million USD | -445486.207% |
| Vericel Corporation | 127.7 Million USD | -5465.248% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -127613.124% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -8226.216% |
| Generation Bio Co. | 171.63 Million USD | -4040.943% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -61433.333% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -16890.031% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -2712.488% |
| Invivyd, Inc. | 51.71 Million USD | -13643.353% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -7627.04% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -109151.741% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -9313.876% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -695992.067% |
| 2seventy bio, Inc. | 310.12 Million USD | -2191.681% |
| ADMA Biologics, Inc. | 193.97 Million USD | -3563.907% |
| Clene Inc. | 38.95 Million USD | -18146.258% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -19569.354% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -2665.667% |
| GeoVax Labs, Inc. | 3.51 Million USD | -201813.076% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -3635.408% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -58252.194% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -3483.617% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -58179.759% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -14672.297% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -13349.973% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -1821.596% |
| Evaxion Biotech A/S | 17.61 Million USD | -40241.184% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -4316.295% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -4539.523% |
| Trevena, Inc. | 48.26 Million USD | -14626.078% |
| Surrozen, Inc. | 8.14 Million USD | -87157.213% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -32810.859% |
| Cingulate Inc. | 10.36 Million USD | -68495.624% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -258340.0% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -18957.975% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -198061.449% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -53946.388% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -2140.567% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -28501.151% |
| Clearmind Medicine Inc. | 3.61 Million USD | -196772.14% |
| Kronos Bio, Inc. | 54.2 Million USD | -13012.489% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -15007.667% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -31126.642% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -35309.795% |
| Statera Biopharma, Inc. | 22.67 Million USD | -31241.321% |
| ImmunityBio, Inc. | 1.09 Billion USD | -551.795% |
| Korro Bio, Inc. | 51.75 Million USD | -13632.996% |
| Kineta, Inc. | 7.22 Million USD | -98309.028% |
| BioVie Inc. | 9.7 Million USD | -73152.987% |
| Codexis, Inc. | 49.94 Million USD | -14129.568% |
| Celularity Inc. | 102.92 Million USD | -6804.857% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -7284.23% |
| Celcuity Inc. | 51.45 Million USD | -13713.585% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -2058771.243% |
| Cibus, Inc. | 206.11 Million USD | -3348.09% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -16632.431% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -26883.181% |
| IN8bio, Inc. | 8.77 Million USD | -80920.292% |
| Kodiak Sciences Inc. | 213.59 Million USD | -3227.434% |
| Annexon, Inc. | 47.11 Million USD | -14983.62% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -7837.258% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -7274.652% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -51818.329% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | -172.994% |
| Eyenovia, Inc. | 19.78 Million USD | -35830.23% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -3913.361% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -92428.317% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -29391.265% |
| Arcellx, Inc. | 339.75 Million USD | -1991.849% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -59633.569% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -2794.477% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -74218.728% |
| Moolec Science SA | 13.94 Million USD | -50863.919% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -16369.92% |
| Geron Corporation | 146.12 Million USD | -4763.646% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -13964.553% |
| Royalty Pharma plc | 6.29 Billion USD | -12.855% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -17767.81% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -2413947.268% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -288773.389% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -3657.269% |
| Humacyte, Inc. | 114.67 Million USD | -6097.494% |
| Structure Therapeutics Inc. | 29.05 Million USD | -24364.214% |
| 89bio, Inc. | 59.96 Million USD | -11752.476% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -26756.743% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -594139.13% |
| Genelux Corporation | 8.42 Million USD | -84307.363% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -103562.485% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -5113.58% |
| Notable Labs, Ltd. | 4.42 Million USD | -160439.869% |
| Liquidia Corporation | 73.13 Million USD | -9617.384% |
| Mustang Bio, Inc. | 17.61 Million USD | -40237.704% |
| Immunovant, Inc. | 48.95 Million USD | -14417.618% |
| Quantum-Si incorporated | 26.63 Million USD | -26587.319% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -18416.27% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -228939.639% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -9522.263% |
| Acasti Pharma Inc. | 11.55 Million USD | -61396.063% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -31336.593% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -261343.655% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -19172.446% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -521391.119% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -116486.286% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -28517.274% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -30555.193% |
| PepGen Inc. | 34.63 Million USD | -20422.364% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -58423.551% |
| United Therapeutics Corporation | 1.18 Billion USD | -501.176% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -101662.6% |
| Solid Biosciences Inc. | 38.45 Million USD | -18380.16% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -82954.104% |
| Immuneering Corporation | 12 Million USD | -59084.626% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -2264331.686% |
| Silo Pharma, Inc. | 1.56 Million USD | -452792.109% |
| Belite Bio, Inc | 4.21 Million USD | -168674.638% |
| XOMA Corporation | 145.58 Million USD | -4781.921% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -292614.168% |
| Bionomics Limited | 10.15 Million USD | -69860.579% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -32970.122% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -30917.763% |
| uniQure N.V. | 624.01 Million USD | -1038.924% |
| Cassava Sciences, Inc. | 14.19 Million USD | -49967.629% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -3932971.759% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -4076.127% |
| Forte Biosciences, Inc. | 3.66 Million USD | -193765.248% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -2727284.365% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -105237.187% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -92428.317% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -40785.348% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -67151.136% |
| Altimmune, Inc. | 16.54 Million USD | -42866.568% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -1050.564% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -30917.763% |
| Compugen Ltd. | 55.77 Million USD | -12642.447% |
| Peak Bio, Inc. | 20.75 Million USD | -34145.532% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -6333.919% |
| Benitec Biopharma Inc. | 4.96 Million USD | -143130.552% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -4402.639% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -9354.2% |
| Zura Bio Limited | 21.29 Million USD | -33279.203% |
| PolyPid Ltd. | 17.46 Million USD | -40586.398% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -6223.099% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -9354.2% |
| Instil Bio, Inc. | 99.8 Million USD | -7021.271% |
| argenx SE | 444.95 Million USD | -1497.277% |
| Immunome, Inc. | 28.65 Million USD | -24699.707% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -85147.691% |
| Verona Pharma plc | 58.84 Million USD | -11978.483% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -49005.921% |
| Shattuck Labs, Inc. | 14.85 Million USD | -47730.271% |
| CervoMed Inc. | 2.59 Million USD | -273697.87% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -145716.578% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -55703.235% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -67361.794% |
| Moolec Science SA | 13.94 Million USD | -50863.919% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -303168.098% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -12683.636% |
| AnaptysBio, Inc. | 364.28 Million USD | -1850.967% |
| Design Therapeutics, Inc. | 11.95 Million USD | -59343.794% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -55932.009% |
| NeurAxis, Inc. | 1.91 Million USD | -371466.638% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -18157.039% |
| Lumos Pharma, Inc. | 13.33 Million USD | -53204.583% |
| Achilles Therapeutics plc | 19.08 Million USD | -37135.291% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -49005.921% |
| 180 Life Sciences Corp. | 5.38 Million USD | -131825.455% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -30030.164% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -31126.642% |
| Nutriband Inc. | 1.07 Million USD | -658624.149% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -23127.335% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -48877.328% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -1671.134% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -21786.182% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -54364.309% |
| Palisade Bio, Inc. | 2.73 Million USD | -259377.912% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -135196.021% |
| Beam Therapeutics Inc. | 478.38 Million USD | -1385.644% |
| Neurogene Inc. | 36.54 Million USD | -19345.402% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -1685.923% |
| AEON Biopharma, Inc. | 159.88 Million USD | -4345.021% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -14815.215% |
| Sesen Bio, Inc. | 30.98 Million USD | -22837.968% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -27276.064% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -93387.215% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -3530.925% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -3600.516% |
| Athira Pharma, Inc. | 30.05 Million USD | -23545.407% |
| Vaccinex, Inc. | 5.94 Million USD | -119507.876% |
| HCW Biologics Inc. | 15.05 Million USD | -47117.16% |
| XOMA Corporation | 145.58 Million USD | -4781.921% |
| Nektar Therapeutics | 267.04 Million USD | -2561.377% |
| Arvinas, Inc. | 644.6 Million USD | -1002.56% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -39978.091% |
| Merus N.V. | 102.15 Million USD | -6857.445% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -4756.235% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -7371.72% |
| Rezolute, Inc. | 11.73 Million USD | -60468.434% |
| Clene Inc. | 38.95 Million USD | -18146.258% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -249501.388% |
| BeyondSpring Inc. | 48.26 Million USD | -14623.943% |
| Synlogic, Inc. | 32.89 Million USD | -21505.411% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -48535.462% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -434851.04% |
| Peak Bio, Inc. | 20.75 Million USD | -34145.532% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -11099.515% |
| Krystal Biotech, Inc. | 39.71 Million USD | -17795.704% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -1786.954% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -7037.864% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -1642301.889% |
| MannKind Corporation | 721.36 Million USD | -885.228% |
| Ikena Oncology, Inc. | 22.33 Million USD | -31720.461% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -340604.698% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -6827.673% |
| Gossamer Bio, Inc. | 249.14 Million USD | -2752.573% |
| CohBar, Inc. | 1.03 Million USD | -687481.145% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -66389.849% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -37211.529% |
| Legend Biotech Corporation | 589.93 Million USD | -1104.73% |
| Mural Oncology plc | 37.92 Million USD | -18638.399% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -5258.349% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -309532.768% |
| Disc Medicine, Inc. | 22.87 Million USD | -30969.29% |
| Champions Oncology, Inc. | 28.03 Million USD | -25250.811% |
| REGENXBIO Inc. | 262.22 Million USD | -2610.275% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -211461.635% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -56602.569% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -52813.173% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -33416.152% |
| Vaxart, Inc. | 34.02 Million USD | -20787.877% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -34757.07% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -24809.329% |
| Cellectis S.A. | 249.57 Million USD | -2747.681% |
| Longeveron Inc. | 5.33 Million USD | -133066.573% |
| Repare Therapeutics Inc. | 41.81 Million USD | -16894.907% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | -195.484% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -11672.959% |
| Revolution Medicines, Inc. | 262.39 Million USD | -2608.529% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -337208.97% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -82291.607% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -60124.557% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -50509.556% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -330309.112% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | -38.007% |
| Denali Therapeutics Inc. | 122.96 Million USD | -5679.869% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -127613.124% |
| Veru Inc. | 32.81 Million USD | -21559.597% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -103366.298% |
| Cingulate Inc. | 10.36 Million USD | -68495.624% |
| Passage Bio, Inc. | 39.26 Million USD | -18001.727% |
| Context Therapeutics Inc. | 4.19 Million USD | -169451.126% |
| Exicure, Inc. | 8.54 Million USD | -83033.7% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -23985.333% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -67677.036% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -32144.907% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -4260.559% |
| Nuvalent, Inc. | 31.82 Million USD | -22233.218% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -111618.276% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -11177.173% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -39383.889% |
| OmniAb, Inc. | 87.4 Million USD | -8031.693% |
| Anew Medical, Inc. | 8.24 Million USD | -86132.387% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -18461.682% |
| Lipocine Inc. | 2.63 Million USD | -269964.663% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -26951.995% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -17574.077% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -26576.489% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -8149.298% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -131488.595% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -8488.952% |
| Ocugen, Inc. | 23.98 Million USD | -29533.907% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -15214.715% |
| Q32 Bio Inc. | 233.12 Million USD | -2948.583% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -78292.897% |
| Alumis Inc. Common Stock | 53.5 Million USD | -13183.802% |
| Equillium, Inc. | 27.95 Million USD | -25321.54% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -3340.162% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -126211.056% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -115783.533% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -4417.435% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -10135.911% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -71154.83% |
| Dominari Holdings Inc. | 4.63 Million USD | -153235.491% |
| Edesa Biotech, Inc. | 1.84 Million USD | -385812.099% |
| vTv Therapeutics Inc. | 29.56 Million USD | -23937.271% |
| Bio-Techne Corporation | 744.34 Million USD | -854.819% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -5536.127% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -1963.282% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -17415.958% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -24443.634% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -7594.998% |
| Nkarta, Inc. | 105.6 Million USD | -6630.208% |
| BioCardia, Inc. | 4.59 Million USD | -154738.78% |
| Iterum Therapeutics plc | 32.66 Million USD | -21659.537% |